Stonepine Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Stonepine Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,489,687	Closed	-$9.16M	–	38
2021 Q3	$9.16M	Buy	4,489,687 +1,184,070	+36%	+$2.76M	4.17%	7
2021 Q2	$9.82M	Buy	3,305,617 +2,859,916	+642%	+$7.55M	5.13%	6
2021 Q1	$1.23M	Sell	445,701 -904,299	-67%	-$2.73M	0.66%	23
2020 Q4	$3.28M	Sell	1,350,000 -574,956	-30%	-$1.39M	2.51%	12
2020 Q3	$4.04M	Buy	+1,924,956	New	+$6.49M	4.2%	7
2020 Q1	–	Sell	-431,853	Closed	-$903K	–	32
2019 Q4	$903K	Buy	+431,853	New	+$828K	0.63%	19
2019 Q3	–	Sell	-162,244	Closed	-$508K	–	31
2019 Q2	$508K	Sell	162,244 -24,830	-13%	-$91.2K	0.35%	23
2019 Q1	$932K	Buy	+187,074	New	+$921K	0.54%	29
2018 Q1	–	Sell	-344,282	Closed	-$2.5M	–	39
2017 Q4	$2.5M	Buy	+344,282	New	+$2.15M	1.5%	18

Stonepine Capital Management's SBBP Position: Q4 2021 in Review

Stonepine Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 4,489,687 shares — an estimated $9.16M sold.

Stonepine Capital Management first reported a position in SBBP in Q4 2017 and held it in 9 quarters. The position peaked at $9.82M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

Stonepine Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
Stonepine Capital Management sold 4,489,687 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $9.16M.
Stonepine Capital Management first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 9 quarters.
Stonepine Capital Management's Strongbridge Biopharma plc. position peaked at $9.82M in Q2 2021.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Stonepine Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.